ubmslateCN-logo-ubm

CN Mobile Logo

Topics:

Breast Cancer

Too Many DCIS Patients Get Axillary Lymph Node Dissection

No benefit of axillary lymph node evaluation has been shown for women with DCIS, yet this lymph node analysis is still often performed in these patients. Image © Blamb / Shutterstock.com.

Breast Cancer

As physicians, we strive to do no harm, and there is a narrow therapeutic window when treating elderly patients with cancer.

Utilization of breast-conserving therapy has increased over the years in early breast cancer but there are still barriers, including socioeconomic factors.

Breast cancer screening for women aged 50 to 74 does reduce breast cancer mortality.

Neoadjuvant TDM-1 was shown to be effective in treating HER2-positive, HR-positive breast cancer compared with trastuzumab, with or without endocrine therapy.

© LUMOimages/Shutterstock.com

Women who exercise may lower their risk, although those who have received hormone replacement therapy may not get the same benefit. Organized programs can help.

The addition of pertuzumab to trastuzumab and docetaxel offers significant improvement over other options in patients with HER2-positive breast cancer.

Management of ductal carcinoma in situ (DCIS) commonly involves excision, radiotherapy, and hormonal therapy. Radiotherapy is employed for local control in breast conservation. Evidence is evolving for several radiotherapy techniques exist beyond standard whole-breast irradiation.

Pages

Subscribe to Breast Cancer on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.